Asset and Capital Structure

Bayer Group Summary Statements of Financial Position

 

 

Dec. 31, 2016

 

March 31, 2017

 

Change

 

 

€ million

 

€ million

 

%

Noncurrent assets

 

51,791

 

51,664

 

−0.2

Current assets

 

30,437

 

33,362

 

+9.6

Assets held for sale

 

10

 

28

 

+180.0

Total current assets

 

30,447

 

33,390

 

+9.7

Total assets

 

82,238

 

85,054

 

+3.4

Equity

 

31,897

 

35,857

 

+12.4

Noncurrent liabilities

 

31,804

 

29,625

 

−6.9

Current liabilities

 

18,537

 

19,572

 

+5.6

Liabilities

 

50,341

 

49,197

 

−2.3

Total equity and liabilities

 

82,238

 

85,054

 

+3.4

  • Between December 31, 2016, and March 31, 2017, total assets increased by €2.8 billion to €85.1 billion.
  • Noncurrent assets were largely unchanged at €51.7 billion. Total current assets climbed to €33.4 billion, due particularly to a €2.1 billion increase in trade accounts receivable.
  • Equity increased by €4.0 billion compared with December 31, 2016, to €35.9 billion. Income after income taxes of €2.3 billion was among the positive factors here, while the sale of Covestro shares led to an additional positive equity effect of approximately €1.5 billion. The decrease – recognized outside profit or loss – in post-employment benefit obligations had a positive effect of €0.4 billion. The equity ratio (equity coverage of total assets) as of March 31, 2017, was 42.2% (December 31, 2016: 38.8%).
  • Liabilities decreased from €50.3 billion to €49.2 billion in the first quarter of 2017. Trade accounts payable declined by €0.7 billion and financial liabilities by €0.6 billion. Provisions for pensions and other post-employment benefits fell by €0.6 billion to €10.5 billion due to actuarial gains. This was mainly attributable to a slight increase in long-term capital market interest rates for high-quality corporate bonds in Germany and the United States. By contrast, other provisions rose by €0.7 billion.